Currently Vice President of Business Development dedicated to the discovery and creation of shareholder value for Life Science companies.
--Extensive Scientific Research experience in Pharmaceutical and Medical Device Companies AMGEN, ALLERGAN
--Experience as Technical Liaison/Advisor for prominent financial institutions focused on Healthcare and Biotech investments
Prior experience includes:
AMGEN: (Research Scientist ) Drug Product Process Development, Drug Engineering, FDA technology- liaison, Product Characterization, Commercial Manufacturing Support, Commercial Drug Development , Drug Formulation and Pre-commercial Drug Product Tech Transfer.
ALLERGAN: (Research Scientist) Project design and management of proprietary materials and data for medical device and medical aesthetic products. Scientific research team lead of collagen and capsular-contracture studies for devices. Biomaterial optimization applying advanced histology, cell culture and immunohistochemistry.
OPUS Point Partners/OPN Capital Markets/ National Securities: Scientific Advisor and technology liaison. Worked alongside lead market strategist and lead biotech analyst at National Securities for The Biotech Group. Lead the due diligence process for the Managing Director at OPN Capital Markets, reviewing product mechanisms,intellectual property and overall technology/concept viability.
Have been an investor for 50+years. Last 20 years have concentrated on biotechs. Have been senior exec with Shell and ITT before retiring 30+ years ago. My working areas were finance, informatics and international management. Taught MBA courses in management, informatics and communications.
I own a production company. Investing is a way for me to have adequate funding for projects.
I've been investing since 2006, learning one stupid mistake and faulty assumption after another. Sound familiar?
My investment interest is mostly in Biotech - this area is fascinating, lucrative and ultimately beneficial to own future health.
My career started over 31 years ago as a pharmaceutical representative. My experiences span the fields of Account Management, Corporate Training, Brand and Marketing Management, Pharmacy Benefit Management Services, Senior Health Care Director, Health Systems Account Management, District and Regional Field Management and National Accounts Director.
These positions, as an amalgam, have provided me with a unique vantage point and exceptional business acumen relative to the transformation of the pharmaceutical industry and the emergence of new therapeutic entities. My investment strategy is a balance between dividend producing pharmaceutical manufacturers, tech companies, emerging markets and innovative niche-players who hold the promise of true innovation in the area of pharmaco and immuno-therapeutics.